z-logo
open-access-imgOpen Access
IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction
Author(s) -
Sjoerd D. Joustra,
Ferdinand Roelfsema,
A.S. Paul van Trotsenburg,
Harald J. Schneider,
Robert P. Kosilek,
Herman M. Kroon,
John G. Logan,
Natalie C. Butterfield,
Xiang Zhou,
Chirine Toufaily,
Beata Bąk,
MarcOlivier Turgeon,
Emilie Brûlé,
Frederik J. Steyn,
Mark Gurnell,
Olympia Koulouri,
Paul Le Tissier,
Pierre Fontanaud,
J. H. Duncan Bassett,
Graham R. Williams,
Wilma Oostdijk,
Jan M. Wit,
Alberto M. Pereira,
Nienke R. Biermasz,
Daniel J. Bernard,
Nadia Schoenmakers
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/clinem/dgz093
Subject(s) - medicine , somatotropic cell , endocrinology , biology , basal (medicine) , pituitary gland , hormone , insulin
The X-linked immunoglobulin superfamily, member 1 (IGSF1), gene is highly expressed in the hypothalamus and in pituitary cells of the POU1F1 lineage. Human loss-of-function mutations in IGSF1 cause central hypothyroidism, hypoprolactinemia, and macroorchidism. Additionally, most affected adults exhibit higher than average IGF-1 levels and anecdotal reports describe acromegaloid features in older subjects. However, somatotrope function has not yet been formally evaluated in this condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom